We discuss the market outlook and ETF strategies for the rest of 2021 (1:00) - Breaking Down Current Stock Market Performance (7:30) - Inflation Concerns: Can We Expect Strong Economic Growth To Continue? (14:20) - ETFs To Keep On Your Radar: How Should Investors Position Their Portfolios? (19:45) - Are Meme Stocks Here To Stay? Podcast@Zacks.com

Best ETF Ideas for the Second Half of 2021

Join us every week to listen to Neena interview fellow ETF experts within their industries

Education

Training

Language Courses

Higher Education

K-12

Educational Technology

Business

Investing

Careers

Management & Marketing

Business News

Shopping

We discuss factors driving Japanese stocks higher. (1:15) - Japanese Stock Market Rally: The Psychological Effect  (8:05) - What Impact Did Corporate Governance And Foreign Investors Have On The Japanese Stock Market Rally? (15:15) - Will This Rally Continue and For How Long? (18:00) - What Are The Current Risks for The Japanese Market? (20:00) - WisdomTree Japanese ETF Suite: DXJ, DFJ, DXJS (25:20) - Episode Roundup: EWJ & FLJP Podcast@Zacks.com

Can the Record Rally in Japan ETFs Continue?

We discuss bond market opportunities amid ‘higher for longer’ interest rates (1:45) - What Should Investors Expect From Interest Rates For The Rest of 2024? (8:00) - Is Now The Time To Step Away From Cash And Invest Into Stocks and Bonds? (12:15) - Where Are The Investment Opportunities Within The Fixed Income Market? (20:10) - Should You Revaluate Your 60/40 Portfolio? (24:05) - What Is Driving The Flows Into Bond ETFs? (28:20) - BlackRock Flexible Income ETF: BINC (33:10) - Episode Roundup: HYDB, ISGB, STIP Podcast@Zacks.com

Fixed Income ETFs: Where Should You Invest Now?

We discuss attractive investment opportunities within the healthcare industry. (1:15) - Learning The Background of Tema ETFs (3:30) - What Are GLP-1 Drugs and How Do They Work? (9:45) - Who Will Be Leaders In Developing These New Drugs? (15:00) - What Are The Most Promising Weight-loss Drugs In Development Right Now? (21:10) - How Will Political Pressure To Reduce Prices Impact These Companies? (25:05) - Tema Obesity & Cardiometabolic ETF: HRTS (29:25) - Tema Oncology ETF: CANC (34:55) - Tema Neuroscience and Mental Health ETF: MNTL (39:30) - Tema American Reshoring ETF: RSHO Podcast@Zacks.com

Healthcare ETFs for the Weight-Loss Drug Boom & Beyond

Should you combine the growth potential of Mag 7 with the stability of dividend growers? (1:00) - How Long Will The Magnificent 7 Stay On Top? (5:10) - Breaking Down The Earnings Reports For The Magnificent 7 (8:00) - Roundhill Magnificent Seven ETF: MAGS (13:25) - Will Dividend Investing Make A Comeback In 2024? (16:00) - Roundhill S&P; Dividend Monarchs ETF: KNGS (22:30) - Bitcoin Covered Call Strategy ETF: YBTC Podcast@Zacks.com

Can Dividend Kings Outperform the Magnificent 7 ETF?

Where can investors find attractive opportunities within the fixed income market? (1:00) - What Should Investors Know About BondBloxx? (5:15) - What Is Driving The Growth In Fixed Income Investing Right Now? (10:15) - What Are The Advantages of Investing In Bond ETFs? (14:00) - How Many Rate Cuts Should Investor Expect This Year? (16:50) - Overview of BondBloxx ETF Suite (20:10) - Episode Roundup: XHLF, XBB, XCCC Podcast@Zacks.com

Best ETF Ideas for the Second Half of 2021

Download our free app to listen on your phone